Erythromycin Stearate 250mg Capsules from Canada
Capsules containing 250mg erythromycin stearate, a macrolide antibiotic in single-ingredient form for skin and soft tissue infections, packaged in measured doses for pharmacy retail. Fits HTS 3004.20.0020 due to erythromycin specificity and retail presentation excluding veterinary uses.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include stability data and bioequivalence studies for ANDA approval; use child-resistant packaging
• Verify no cross-contamination with beta-lactams
• Declare exact potency to avoid duty disputes